Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-1: Bazedoxifene/Conjugated Estrogens in Postmenopausal Women
NCT00675688Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2002
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bazedoxifene, conjugated estrogens in endometrial hyperplasia (EH), osteoporosis, vasomotor symptoms, sponsored by Pfizer. Started Apr 2002; status: completed.
02
Drugs
bazedoxifeneconjugated estrogens
03
Conditions
endometrial hyperplasia (EH)osteoporosisvasomotor symptoms
Beyond the preview
Go deeper on NCT00675688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675688.